Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Ishikawa T, Itabashi M
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.
Cancer. 1990 Dec 1;66(11):2319-23. doi: 10.1002/1097-0142(19901201)66:11<2319::aid-cncr2820661111>3.0.co;2-1.
We report 92 patients treated with esophagectomy for superficial esophageal carcinoma (SEC; 9.1% of all resected esophageal cancers at our institution). The operative mortality rate was 5.4%. In 24 cases, cancer invasion was limited to the mucosa, and in 68 to the submucosa. Twenty-three patients in the former group had no lymph node involvement, whereas 24 patients (35.3%) of the latter group had lymph node metastases. The 5-year survival rate after surgery for patients with SEC limited to the mucosa was 83.5%, which was significantly better than that for carcinoma invading the submucosa (54.9%). No recurrent disease occurred in patients with lesions limited to the mucosa. In conclusion, an esophagectomy with wide lymphadenectomy is necessary to provide a better prognosis for SEC invading the submucosa, whereas a less extensive treatment may be considered for SEC limited to the mucosa.